ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
921 |
282K |
55 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
921
|
282K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
921 |
282K |
50 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
921
|
282K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
13 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
46K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
24 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
46K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
36 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
46K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
62 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
46K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
73 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
46K
|
73
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
44 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
46K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
18 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
46K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
45 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
46K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Mason14
|
38 |
8.4K |
6 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.4K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Mason14
|
38 |
8.4K |
43 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.4K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
50 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
46K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
50 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
46K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
96K |
55 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
307
|
96K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
46K |
76 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
146
|
46K
|
76
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
921 |
282K |
71 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
921
|
282K
|
71
|
|
ASX - By Stock
|
RAC |
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
96K |
130 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
307
|
96K
|
130
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
921 |
282K |
15 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
921
|
282K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
52 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
391
|
85K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
44 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
52 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
40 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
43 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
43 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
35 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
61 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
37 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
85K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
39 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
85K
|
39
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
4.2M |
106 |
10/07/24 |
10/07/24 |
General
|
11K
|
4.2M
|
106
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
23 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
85K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
66 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
85K
|
66
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
35 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
85K
|
35
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
4.2M |
73 |
09/07/24 |
09/07/24 |
General
|
11K
|
4.2M
|
73
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
4.2M |
91 |
09/07/24 |
09/07/24 |
General
|
11K
|
4.2M
|
91
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
66 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
85K
|
66
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
85K |
9 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
85K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Mason14
|
15K |
7.5M |
10 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
15K
|
7.5M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Mason14
|
15K |
7.5M |
2 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
15K
|
7.5M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
Mason14
|
71 |
27K |
10 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
71
|
27K
|
10
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
4
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
18 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
18
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
18 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
18
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
15 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
15
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
14 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
7 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
27K
|
13M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Mason14
|
168 |
49K |
121 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
49K
|
121
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
14 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
27K
|
13M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
20 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
27K
|
13M
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Mason14
|
130 |
39K |
44 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
130
|
39K
|
44
|
|